Symmetry based viral antagonists
AssigneeCity of Hope
InventorsJohn C. WILLIAMS, Miso PARK, Juliet GONZALES
Life of this patent
Estimating the term…
Loading patent…
AssigneeCity of Hope
InventorsJohn C. WILLIAMS, Miso PARK, Juliet GONZALES
Estimating the term…
Provided herein are, inter alia, peptides capable of binding viral proteins and thereby preventing viral infection, replication and spread (e.g., SARS CoV-2). The conjugates provided herein include a trimerizing domain (e.g., a collagen 18 trimerizing domain) attached through a peptide linker to a viral protein binding domain (e.g., a spike binding domain). The peptides and trimeric compositions provided herein exhibit a unique trimeric symmetry which results in superior binding affinities and low binding entropies providing for desirable compositions inhibit viral entry and treating viral infection.
A peptide comprising a collagen trimerizing domain bound to a viral protein binding domain through a chemical linker.
A peptide complex comprising:
Dependencies are inferred from the claim text.